<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span><span class="HistoricalNote">1993, c. 2, s. 7</span></p><p class="Section amending"><strong><a class="sectionLabel" id="s-52"><span class="sectionLabel">52</span></a></strong> Subsection 85(3) of the Act is replaced by the following:</p><section><div class="AmendedText"><ul class="ProvisionList"><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Research costs</p><p class="Subsection"><a class="lawLabel" id="s-52AmendedTextss-(3)ID0EBAAA"><span class="lawlabel">(3)</span></a> In determining under section 83 whether a medicine is being or has been sold in any market in Canada at an excessive price, the Board shall not take into consideration research costs other than the Canadian portion of the world costs related to the research that led to the invention pertaining to that medicine or to the development and commercialization of that invention, calculated in proportion to the ratio of sales by the rights holder in Canada of that medicine to total world sales.</p></li></ul></div></section>
